Covert pharmaceutical promotion in free medical journals

doi:10.1503/cmaj.110156

Comment

. 2011 Mar 22;183(5):534-5.

doi: 10.1503/cmaj.110156. Epub 2011 Feb 28.

Covert pharmaceutical promotion in free medical journals

Aaron S Kesselheim¹

Affiliations

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department ofMedicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass, USA. akesselheim@partners.org

PMID: 21398227
PMCID: PMC3060177
DOI: 10.1503/cmaj.110156

Comment

Covert pharmaceutical promotion in free medical journals

Aaron S Kesselheim. CMAJ. 2011.

. 2011 Mar 22;183(5):534-5.

doi: 10.1503/cmaj.110156. Epub 2011 Feb 28.

Author

Aaron S Kesselheim¹

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department ofMedicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass, USA. akesselheim@partners.org

PMID: 21398227
PMCID: PMC3060177
DOI: 10.1503/cmaj.110156

No abstract available

PubMed Disclaimer

Comment on

The association between a journal's source of revenue and the drug recommendations made in the articles it publishes.
Becker A, Dörter F, Eckhardt K, Viniol A, Baum E, Kochen MM, Lexchin J, Wegscheider K, Donner-Banzhoff N. Becker A, et al. CMAJ. 2011 Mar 22;183(5):544-8. doi: 10.1503/cmaj.100951. Epub 2011 Feb 28. CMAJ. 2011. PMID: 21398223 Free PMC article.

References

1. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4–8 - PubMed
1. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf 2011; 20:177–84 - PMC - PubMed
1. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429–33 - PubMed
1. Pollack A. Stanford to ban drug makers’ gifts to doctors, even pens. New York Times 2006. September 12 Available: www.nytimes.com/2006/09/12/business/12drug.html (accessed 2011 Feb. 8) - PubMed
1. Mello MM, Studdert DM, Brennan TA. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med 2009;360:1557–66 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources

[1] Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4–8 - PubMed

[2] Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4–8 - PubMed

[3] Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf 2011; 20:177–84 - PMC - PubMed

[4] Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf 2011; 20:177–84 - PMC - PubMed

[5] Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429–33 - PubMed

[6] Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429–33 - PubMed

[7] Pollack A. Stanford to ban drug makers’ gifts to doctors, even pens. New York Times 2006. September 12 Available: www.nytimes.com/2006/09/12/business/12drug.html (accessed 2011 Feb. 8) - PubMed

[8] Pollack A. Stanford to ban drug makers’ gifts to doctors, even pens. New York Times 2006. September 12 Available: www.nytimes.com/2006/09/12/business/12drug.html (accessed 2011 Feb. 8) - PubMed

[9] Mello MM, Studdert DM, Brennan TA. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med 2009;360:1557–66 - PubMed

[10] Mello MM, Studdert DM, Brennan TA. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med 2009;360:1557–66 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Covert pharmaceutical promotion in free medical journals

Affiliation

Covert pharmaceutical promotion in free medical journals

Author

Affiliation

Comment on

Similar articles

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources